A multicentre, retrospective study to evaluate the safety, efficacy, and tolerability of Simeprevir and Sofosbuvir with or without Ribavirin in patients with hepatitis C genotype-1 infection after an orthotopic liver transplantation

Trial Profile

A multicentre, retrospective study to evaluate the safety, efficacy, and tolerability of Simeprevir and Sofosbuvir with or without Ribavirin in patients with hepatitis C genotype-1 infection after an orthotopic liver transplantation

Completed
Phase of Trial: Phase IV

Latest Information Update: 02 Mar 2016

At a glance

  • Drugs Simeprevir (Primary) ; Sofosbuvir (Primary) ; Ribavirin
  • Indications Hepatitis C
  • Focus Therapeutic Use
  • Most Recent Events

    • 02 Mar 2016 New trial record
    • 25 Feb 2016 Results published in the Liver Transplantation
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top